Cargando…

OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control

Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachmann, Freya, Koch, Gilbert, Pfister, Marc, Szinnai, Gabor, Schropp, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550736/
https://www.ncbi.nlm.nih.gov/pubmed/34720180
http://dx.doi.org/10.1007/s10957-021-01819-w
_version_ 1784591019365367808
author Bachmann, Freya
Koch, Gilbert
Pfister, Marc
Szinnai, Gabor
Schropp, Johannes
author_facet Bachmann, Freya
Koch, Gilbert
Pfister, Marc
Szinnai, Gabor
Schropp, Johannes
author_sort Bachmann, Freya
collection PubMed
description Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic–pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic–pharmacodynamic examples.
format Online
Article
Text
id pubmed-8550736
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85507362021-10-29 OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control Bachmann, Freya Koch, Gilbert Pfister, Marc Szinnai, Gabor Schropp, Johannes J Optim Theory Appl Article Providing the optimal dosing strategy of a drug for an individual patient is an important task in pharmaceutical sciences and daily clinical application. We developed and validated an optimal dosing algorithm (OptiDose) that computes the optimal individualized dosing regimen for pharmacokinetic–pharmacodynamic models in substantially different scenarios with various routes of administration by solving an optimal control problem. The aim is to compute a control that brings the underlying system as closely as possible to a desired reference function by minimizing a cost functional. In pharmacokinetic–pharmacodynamic modeling, the controls are the administered doses and the reference function can be the disease progression. Drug administration at certain time points provides a finite number of discrete controls, the drug doses, determining the drug concentration and its effect on the disease progression. Consequently, rewriting the cost functional gives a finite-dimensional optimal control problem depending only on the doses. Adjoint techniques allow to compute the gradient of the cost functional efficiently. This admits to solve the optimal control problem with robust algorithms such as quasi-Newton methods from finite-dimensional optimization. OptiDose is applied to three relevant but substantially different pharmacokinetic–pharmacodynamic examples. Springer US 2021-02-24 2021 /pmc/articles/PMC8550736/ /pubmed/34720180 http://dx.doi.org/10.1007/s10957-021-01819-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bachmann, Freya
Koch, Gilbert
Pfister, Marc
Szinnai, Gabor
Schropp, Johannes
OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title_full OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title_fullStr OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title_full_unstemmed OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title_short OptiDose: Computing the Individualized Optimal Drug Dosing Regimen Using Optimal Control
title_sort optidose: computing the individualized optimal drug dosing regimen using optimal control
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550736/
https://www.ncbi.nlm.nih.gov/pubmed/34720180
http://dx.doi.org/10.1007/s10957-021-01819-w
work_keys_str_mv AT bachmannfreya optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol
AT kochgilbert optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol
AT pfistermarc optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol
AT szinnaigabor optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol
AT schroppjohannes optidosecomputingtheindividualizedoptimaldrugdosingregimenusingoptimalcontrol